The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Nitric oxide synthases (NOS) and their substrate arginine play roles in cell proliferation and apoptosis.
• Nitric oxide synthase 2 (NOS2) is implicated in various disease processes, including cancer.
• The Apc(Min/+) mouse model is widely used to study intestinal tumorigenesis.

Purpose of the Study:

• To investigate the roles of dietary arginine and NOS2 in Apc-dependent intestinal tumorigenesis.
• To determine how the presence or absence of a functional Nos2 gene influences tumor development.
• To explore the molecular mechanisms underlying arginine's effects on tumor growth in the context of NOS2 expression.

Main Methods:

• Utilized Apc(Min/+) mice with and without a functional Nos2 gene.
• Administered dietary arginine supplementation (0.2% and 2%) via drinking water.
• Assessed intestinal tumor number, size, and incidence.
• Analyzed nitrotyrosine formation and apoptosis in intestinal tissues.
• Examined the expression of NOS2 and NOS3 in different experimental groups.

Main Results:

• In the absence of NOS2, dietary arginine decreased small and large intestinal tumor burden.
• Supplemental arginine in Nos2 knockout mice led to reduced tumor number/size, increased nitrotyrosine, and apoptosis in the small intestine.
• In mice expressing NOS2, arginine increased colon tumor number/incidence and nitrotyrosine formation, without affecting apoptosis.
• Loss of Nos2 correlated with decreased tumorigenesis when arginine was supplemented.

Conclusions:

• NOS2 and dietary arginine significantly influence intestinal and colonic tumorigenesis in Min mice.
• NOS2 prevents arginine-induced tumor reduction in the small intestine, associated with NOS3 expression and apoptosis.
• NOS2 is essential for arginine-induced tumor promotion in the colon, linked to increased nitrotyrosine formation.